Teaching Hospitals NHS Trust, Academic Unit of

Handling Tore
K Kvien
Nihr Leeds Musculoskeletal
Cliniques Universitaires Saint
Université Catholique De
Immunology
Rheumatology F

January 2012

Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheuma...

Pharmacology and clinical study of abatacept in the treatment of rheumatoid arthritis

刘宁
傅得兴
孙春华

January 2007

阿贝西普是一种选择性共刺激调节剂,用于缓解病情抗风湿药疗效不佳的中至重度活动性类风湿性关节炎(RA)的成年患者,以改善RA的症状和体征,减缓骨结构的损伤进程,提高患者的机体功能.现对其药理作用、药动学...

Modulating the co-stimulatory signal for T cell activation in rheumatoid arthritis: Could it be the first step of the treatment?

CAPORALI, ROBERTO
BUGATTI, SERENA
CAVAGNA, LORENZO
Antivalle M.
Sarzi Puttini P.

January 2014

Advances in our understanding of the key mediators of chronic inflammation and tissue damage in rheu...

Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study.

Buch, MH
Boyle, DL
Rosengren, S
Saleem, B
Reece, RJ
Rhodes, LA
Radjenovic, A
English, A
Tang, H
Vratsanos, G
O'Connor, P
Firestein, GS
Emery, P

July 2009

ObjectivesAbatacept is the only agent currently approved to treat rheumatoid arthritis (RA) that tar...

Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study

Buch, MH
Boyle, DL
Rosengren, S
Saleem, B
Reece, RJ
Rhodes, LA
Radjenovic, A
English, A
Tang, H
Vratsanos, G
O'Connor, P
Firestein, GS
Emery, P

June 2009

Objectives: Abatacept is the only agent currently approved to treat rheumatoid arthritis (RA) that t...

Abatacept in the treatment of rheumatoid arthritis

Buch, MH
Vital, EM
Emery, P

October 2008

T-cell biology has regained importance in the pathogenesis of rheumatoid arthritis. Despite the sign...

Modulation of T-Cell Co-Stimulation in Rheumatoid Arthritis Clinical Experience with Abatacept

Bruno Lagana'
Marta Vinciguerra
Raffaele D'Amelio

January 2009

Rheumatoid arthritis (RA), characterized by progressive joint destruction, deformity, disability and...

Correspondence to

Daniel H Solomon
Marc C Hochberg
Jeffrey D Greenberg
Department Of Immunology

January 2013

The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumato...

Safety and efficacy of abatacept among patients with refractory rheumatoid arthritis: Experience from a North Indian Tertiary Care Hospital

M N Arjun
Arun Hegde
Krishnan Shanmuganandan
Darshan S Bhakuni
Kavita Singh
Abhishek Kumar

January 2018

Background: T-cells are pathogenic in rheumatoid arthritis (RA) and have an important role in persis...

THERAPEUTIC MAINTENANCE OF ABATACEPT IN RHEUMATOID ARTHRITIS: RESULTS OF THE RIC-ABA STUDY (517 PATIENTS)

Salmon, J. H.
Letarouilly, U. G.
Coquerelle, P.
Goeb, Vincent
Guyot, M. H.
Houvenagel, E.
Lecuyer, N.
Le Dantec, L.
Marguerie, L.
Morel, G.
Baudens, G.
Solau, E.
Flipo, R. -M.

January 2018

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, NETHERLANDS, JUN 13-16, 2018I...

Memory B Cells and Response to Abatacept in Rheumatoid Arthritis.

Gazeau, Pierre
Alegria, Guillermo Carvajal
Devauchelle-Pensec, Valérie
Christophe, Jamin
Lemerle, Julie
Bendaoud, Boutahar
Brooks, Wesley H
Saraux, Alain
Cornec, Divi
Renaudineau, Yves

May 2017

International audienceAbatacept is a fusion protein (CTLA4-Ig) and therapeutic molecule labeled for ...

Comparative clinical utility of once-weekly subcutaneous abatacept in the management of rheumatoid arthritis

Rakieh C
Conaghan PG

April 2014

Chadi Rakieh, Philip G ConaghanLeeds Institute of Rheumatic and Musculoskeletal Medicine, University...

Abatacept (Orencia®), the first T-lymphocyte co-stimulation modulator, for use in rheumatoid arthritis

Boyce, Eric G.

July 2006

Abatacept (Orencia, Bristol-Myers Squibb) is the first T-lymphocyte co-stimulation modulator to ...

Chapel Allerton Hospital

Phd S
Ra Overfield
Ms Keqin Qi
Phd Rene Westhovens
Leeds Ls Sa

December 2014

1 The impact of T-cell co-stimulation modulation in patients with undifferentiated inflammatory arth...

Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol

Al-Laith, M.
Jasenecova, M.
Abraham, S.
Bosworth, A.
Bruce, I.N.
Buckley, C.D.
Ciurtin, C.
D'Agostino, M.A.
Emery, P.
Gaston, H.
Isaacs, J.D.
Filer, A.
Fisher, B.A.
Huizinga, T.W.J.
Ho, P.
Jacklin, C.
Lempp, H.
McInnes, I.B.
Pratt, A.G.
Ostor, A.
Raza, K.
Taylor, P.C.
Schaardenburg, D. van
Shivapatham, D.
Wright, A.J.
Vasconcelos, J.C.
Kelly, J.
Murphy, C.
Prevost, A.T.
Cope, A.P.

July 2019

Trial designWe present a study protocol for a multi-centre, randomised, double-blind, parallel-group...

5Department of Clinical

Handling Tore
K Kvien
Nihr Leeds Musculoskeletal
Cliniques Universitaires Saint
Université Catholique De
Immunology
Rheumatology F

January 2012

Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheuma...

Pharmacology and clinical study of abatacept in the treatment of rheumatoid arthritis

刘宁
傅得兴
孙春华

January 2007

阿贝西普是一种选择性共刺激调节剂,用于缓解病情抗风湿药疗效不佳的中至重度活动性类风湿性关节炎(RA)的成年患者,以改善RA的症状和体征,减缓骨结构的损伤进程,提高患者的机体功能.现对其药理作用、药动学...

Modulating the co-stimulatory signal for T cell activation in rheumatoid arthritis: Could it be the first step of the treatment?

CAPORALI, ROBERTO
BUGATTI, SERENA
CAVAGNA, LORENZO
Antivalle M.
Sarzi Puttini P.

January 2014

Advances in our understanding of the key mediators of chronic inflammation and tissue damage in rheu...

Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study.

Buch, MH
Boyle, DL
Rosengren, S
Saleem, B
Reece, RJ
Rhodes, LA
Radjenovic, A
English, A
Tang, H
Vratsanos, G
O'Connor, P
Firestein, GS
Emery, P

July 2009

ObjectivesAbatacept is the only agent currently approved to treat rheumatoid arthritis (RA) that tar...

Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study

Buch, MH
Boyle, DL
Rosengren, S
Saleem, B
Reece, RJ
Rhodes, LA
Radjenovic, A
English, A
Tang, H
Vratsanos, G
O'Connor, P
Firestein, GS
Emery, P

June 2009

Objectives: Abatacept is the only agent currently approved to treat rheumatoid arthritis (RA) that t...

Abatacept in the treatment of rheumatoid arthritis

Buch, MH
Vital, EM
Emery, P

October 2008

T-cell biology has regained importance in the pathogenesis of rheumatoid arthritis. Despite the sign...

Modulation of T-Cell Co-Stimulation in Rheumatoid Arthritis Clinical Experience with Abatacept

Bruno Lagana'
Marta Vinciguerra
Raffaele D'Amelio

January 2009

Rheumatoid arthritis (RA), characterized by progressive joint destruction, deformity, disability and...

Correspondence to

Daniel H Solomon
Marc C Hochberg
Jeffrey D Greenberg
Department Of Immunology

January 2013

The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumato...

Safety and efficacy of abatacept among patients with refractory rheumatoid arthritis: Experience from a North Indian Tertiary Care Hospital

M N Arjun
Arun Hegde
Krishnan Shanmuganandan
Darshan S Bhakuni
Kavita Singh
Abhishek Kumar

January 2018

Background: T-cells are pathogenic in rheumatoid arthritis (RA) and have an important role in persis...

THERAPEUTIC MAINTENANCE OF ABATACEPT IN RHEUMATOID ARTHRITIS: RESULTS OF THE RIC-ABA STUDY (517 PATIENTS)

Salmon, J. H.
Letarouilly, U. G.
Coquerelle, P.
Goeb, Vincent
Guyot, M. H.
Houvenagel, E.
Lecuyer, N.
Le Dantec, L.
Marguerie, L.
Morel, G.
Baudens, G.
Solau, E.
Flipo, R. -M.

January 2018

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, NETHERLANDS, JUN 13-16, 2018I...

Memory B Cells and Response to Abatacept in Rheumatoid Arthritis.

Gazeau, Pierre
Alegria, Guillermo Carvajal
Devauchelle-Pensec, Valérie
Christophe, Jamin
Lemerle, Julie
Bendaoud, Boutahar
Brooks, Wesley H
Saraux, Alain
Cornec, Divi
Renaudineau, Yves

May 2017

International audienceAbatacept is a fusion protein (CTLA4-Ig) and therapeutic molecule labeled for ...

Comparative clinical utility of once-weekly subcutaneous abatacept in the management of rheumatoid arthritis

Rakieh C
Conaghan PG

April 2014

Chadi Rakieh, Philip G ConaghanLeeds Institute of Rheumatic and Musculoskeletal Medicine, University...

Abatacept (Orencia®), the first T-lymphocyte co-stimulation modulator, for use in rheumatoid arthritis

Boyce, Eric G.

July 2006

Abatacept (Orencia, Bristol-Myers Squibb) is the first T-lymphocyte co-stimulation modulator to ...

Chapel Allerton Hospital

Phd S
Ra Overfield
Ms Keqin Qi
Phd Rene Westhovens
Leeds Ls Sa

December 2014

1 The impact of T-cell co-stimulation modulation in patients with undifferentiated inflammatory arth...

Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol

Al-Laith, M.
Jasenecova, M.
Abraham, S.
Bosworth, A.
Bruce, I.N.
Buckley, C.D.
Ciurtin, C.
D'Agostino, M.A.
Emery, P.
Gaston, H.
Isaacs, J.D.
Filer, A.
Fisher, B.A.
Huizinga, T.W.J.
Ho, P.
Jacklin, C.
Lempp, H.
McInnes, I.B.
Pratt, A.G.
Ostor, A.
Raza, K.
Taylor, P.C.
Schaardenburg, D. van
Shivapatham, D.
Wright, A.J.
Vasconcelos, J.C.
Kelly, J.
Murphy, C.
Prevost, A.T.
Cope, A.P.

July 2019

Trial designWe present a study protocol for a multi-centre, randomised, double-blind, parallel-group...

5Department of Clinical

Handling Tore
K Kvien
Nihr Leeds Musculoskeletal
Cliniques Universitaires Saint
Université Catholique De
Immunology
Rheumatology F

January 2012

Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheuma...

Pharmacology and clinical study of abatacept in the treatment of rheumatoid arthritis

刘宁
傅得兴
孙春华

January 2007

阿贝西普是一种选择性共刺激调节剂,用于缓解病情抗风湿药疗效不佳的中至重度活动性类风湿性关节炎(RA)的成年患者,以改善RA的症状和体征,减缓骨结构的损伤进程,提高患者的机体功能.现对其药理作用、药动学...

Modulating the co-stimulatory signal for T cell activation in rheumatoid arthritis: Could it be the first step of the treatment?

CAPORALI, ROBERTO
BUGATTI, SERENA
CAVAGNA, LORENZO
Antivalle M.
Sarzi Puttini P.

January 2014

Advances in our understanding of the key mediators of chronic inflammation and tissue damage in rheu...

Teaching Hospitals NHS Trust, Academic Unit of

Abstract

Extracted data

Teaching Hospitals NHS Trust, Academic Unit of

Abstract

Extracted data

Related items

Related items